Antiadhesion effects of docosahexaenoic acid on normal human peritoneal and adhesion fibroblasts

Rahi Victory, Ghassan M. Saed, Michael Peter Diamond

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective: To determine whether docosahexaenoic acid (DHA) reduces adhesion marker mRNA levels in normal peritoneal and adhesion fibroblasts. Design: Prospective experimental study. Setting: University Medical Center. Patient(s): Three patients undergoing laparotomy with excision of adhesions and normal peritoneum. Intervention(s): DHA treatment (100 μM) of cell cultures for 24 hours. Main Outcome Measure(s): Real-time reverse transcriptase polymerase chain reaction (RT-PCR) quantification of relative changes (mRNA copies/μg mRNA) in mRNA levels of type I collagen, vascular endothelial growth factor (VEGF), and transforming growth factor-β1 (TGF-β1). Result(s): The DHA treatment significantly reduced type I collagen and VEGF, but not TGF-β1 mRNA levels in normal peritoneal fibroblasts compared to normal controls. The DHA treatment of adhesion fibroblasts reduced type I collagen mRNAs to those of normal peritoneal fibroblasts, decreasing mRNAs by 35% compared to untreated adhesion fibroblasts. The VEGF mRNA levels were 50% lower in DHA-treated adhesion fibroblasts versus untreated adhesion fibroblasts. Docasahexaenoic acid reduced TGF- β1 mRNA to normal levels in treated adhesion fibroblasts compared to untreated normal peritoneal fibroblasts. Conclusion(s): Docasahexaenoic acid substantially reduces levels of adhesion-related markers in normal peritoneal and adhesion fibroblasts. This study provides the molecular basis for an easily administered and potentially, highly efficacious, antiadhesion adjuvant.

Original languageEnglish (US)
Pages (from-to)1657-1662
Number of pages6
JournalFertility and Sterility
Volume88
Issue number6
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Docosahexaenoic Acids
Fibroblasts
Messenger RNA
Collagen Type I
Vascular Endothelial Growth Factor A
Transforming Growth Factors
Acids
Peritoneum
Reverse Transcriptase Polymerase Chain Reaction
Laparotomy
Real-Time Polymerase Chain Reaction
Research Design
Therapeutics
Cell Culture Techniques
Outcome Assessment (Health Care)
Prospective Studies

Keywords

  • DHA
  • Docosahexaenoic acid
  • adhesion barriers
  • adhesions
  • inflammation
  • omega 3
  • peritoneum
  • transforming growth factor-β1
  • type I collagen
  • vascular endothelial growth factor

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Antiadhesion effects of docosahexaenoic acid on normal human peritoneal and adhesion fibroblasts. / Victory, Rahi; Saed, Ghassan M.; Diamond, Michael Peter.

In: Fertility and Sterility, Vol. 88, No. 6, 01.12.2007, p. 1657-1662.

Research output: Contribution to journalArticle

@article{4ce6ff84f19047c2bb6f7edb29a7f27e,
title = "Antiadhesion effects of docosahexaenoic acid on normal human peritoneal and adhesion fibroblasts",
abstract = "Objective: To determine whether docosahexaenoic acid (DHA) reduces adhesion marker mRNA levels in normal peritoneal and adhesion fibroblasts. Design: Prospective experimental study. Setting: University Medical Center. Patient(s): Three patients undergoing laparotomy with excision of adhesions and normal peritoneum. Intervention(s): DHA treatment (100 μM) of cell cultures for 24 hours. Main Outcome Measure(s): Real-time reverse transcriptase polymerase chain reaction (RT-PCR) quantification of relative changes (mRNA copies/μg mRNA) in mRNA levels of type I collagen, vascular endothelial growth factor (VEGF), and transforming growth factor-β1 (TGF-β1). Result(s): The DHA treatment significantly reduced type I collagen and VEGF, but not TGF-β1 mRNA levels in normal peritoneal fibroblasts compared to normal controls. The DHA treatment of adhesion fibroblasts reduced type I collagen mRNAs to those of normal peritoneal fibroblasts, decreasing mRNAs by 35{\%} compared to untreated adhesion fibroblasts. The VEGF mRNA levels were 50{\%} lower in DHA-treated adhesion fibroblasts versus untreated adhesion fibroblasts. Docasahexaenoic acid reduced TGF- β1 mRNA to normal levels in treated adhesion fibroblasts compared to untreated normal peritoneal fibroblasts. Conclusion(s): Docasahexaenoic acid substantially reduces levels of adhesion-related markers in normal peritoneal and adhesion fibroblasts. This study provides the molecular basis for an easily administered and potentially, highly efficacious, antiadhesion adjuvant.",
keywords = "DHA, Docosahexaenoic acid, adhesion barriers, adhesions, inflammation, omega 3, peritoneum, transforming growth factor-β1, type I collagen, vascular endothelial growth factor",
author = "Rahi Victory and Saed, {Ghassan M.} and Diamond, {Michael Peter}",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/j.fertnstert.2007.01.123",
language = "English (US)",
volume = "88",
pages = "1657--1662",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Antiadhesion effects of docosahexaenoic acid on normal human peritoneal and adhesion fibroblasts

AU - Victory, Rahi

AU - Saed, Ghassan M.

AU - Diamond, Michael Peter

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Objective: To determine whether docosahexaenoic acid (DHA) reduces adhesion marker mRNA levels in normal peritoneal and adhesion fibroblasts. Design: Prospective experimental study. Setting: University Medical Center. Patient(s): Three patients undergoing laparotomy with excision of adhesions and normal peritoneum. Intervention(s): DHA treatment (100 μM) of cell cultures for 24 hours. Main Outcome Measure(s): Real-time reverse transcriptase polymerase chain reaction (RT-PCR) quantification of relative changes (mRNA copies/μg mRNA) in mRNA levels of type I collagen, vascular endothelial growth factor (VEGF), and transforming growth factor-β1 (TGF-β1). Result(s): The DHA treatment significantly reduced type I collagen and VEGF, but not TGF-β1 mRNA levels in normal peritoneal fibroblasts compared to normal controls. The DHA treatment of adhesion fibroblasts reduced type I collagen mRNAs to those of normal peritoneal fibroblasts, decreasing mRNAs by 35% compared to untreated adhesion fibroblasts. The VEGF mRNA levels were 50% lower in DHA-treated adhesion fibroblasts versus untreated adhesion fibroblasts. Docasahexaenoic acid reduced TGF- β1 mRNA to normal levels in treated adhesion fibroblasts compared to untreated normal peritoneal fibroblasts. Conclusion(s): Docasahexaenoic acid substantially reduces levels of adhesion-related markers in normal peritoneal and adhesion fibroblasts. This study provides the molecular basis for an easily administered and potentially, highly efficacious, antiadhesion adjuvant.

AB - Objective: To determine whether docosahexaenoic acid (DHA) reduces adhesion marker mRNA levels in normal peritoneal and adhesion fibroblasts. Design: Prospective experimental study. Setting: University Medical Center. Patient(s): Three patients undergoing laparotomy with excision of adhesions and normal peritoneum. Intervention(s): DHA treatment (100 μM) of cell cultures for 24 hours. Main Outcome Measure(s): Real-time reverse transcriptase polymerase chain reaction (RT-PCR) quantification of relative changes (mRNA copies/μg mRNA) in mRNA levels of type I collagen, vascular endothelial growth factor (VEGF), and transforming growth factor-β1 (TGF-β1). Result(s): The DHA treatment significantly reduced type I collagen and VEGF, but not TGF-β1 mRNA levels in normal peritoneal fibroblasts compared to normal controls. The DHA treatment of adhesion fibroblasts reduced type I collagen mRNAs to those of normal peritoneal fibroblasts, decreasing mRNAs by 35% compared to untreated adhesion fibroblasts. The VEGF mRNA levels were 50% lower in DHA-treated adhesion fibroblasts versus untreated adhesion fibroblasts. Docasahexaenoic acid reduced TGF- β1 mRNA to normal levels in treated adhesion fibroblasts compared to untreated normal peritoneal fibroblasts. Conclusion(s): Docasahexaenoic acid substantially reduces levels of adhesion-related markers in normal peritoneal and adhesion fibroblasts. This study provides the molecular basis for an easily administered and potentially, highly efficacious, antiadhesion adjuvant.

KW - DHA

KW - Docosahexaenoic acid

KW - adhesion barriers

KW - adhesions

KW - inflammation

KW - omega 3

KW - peritoneum

KW - transforming growth factor-β1

KW - type I collagen

KW - vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=36749092870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36749092870&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2007.01.123

DO - 10.1016/j.fertnstert.2007.01.123

M3 - Article

C2 - 17482172

AN - SCOPUS:36749092870

VL - 88

SP - 1657

EP - 1662

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -